1. Home
  2. IMNM vs MBIN Comparison

IMNM vs MBIN Comparison

Compare IMNM & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • MBIN
  • Stock Information
  • Founded
  • IMNM 2006
  • MBIN 1990
  • Country
  • IMNM United States
  • MBIN United States
  • Employees
  • IMNM N/A
  • MBIN N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • MBIN Major Banks
  • Sector
  • IMNM Health Care
  • MBIN Finance
  • Exchange
  • IMNM Nasdaq
  • MBIN Nasdaq
  • Market Cap
  • IMNM 1.2B
  • MBIN 1.5B
  • IPO Year
  • IMNM 2020
  • MBIN 2017
  • Fundamental
  • Price
  • IMNM $18.12
  • MBIN $30.84
  • Analyst Decision
  • IMNM Strong Buy
  • MBIN Buy
  • Analyst Count
  • IMNM 8
  • MBIN 3
  • Target Price
  • IMNM $25.75
  • MBIN $39.67
  • AVG Volume (30 Days)
  • IMNM 1.4M
  • MBIN 156.3K
  • Earning Date
  • IMNM 11-06-2025
  • MBIN 10-28-2025
  • Dividend Yield
  • IMNM N/A
  • MBIN 1.25%
  • EPS Growth
  • IMNM N/A
  • MBIN N/A
  • EPS
  • IMNM N/A
  • MBIN 4.34
  • Revenue
  • IMNM $9,679,000.00
  • MBIN $597,247,000.00
  • Revenue This Year
  • IMNM N/A
  • MBIN $4.47
  • Revenue Next Year
  • IMNM $85.36
  • MBIN $7.93
  • P/E Ratio
  • IMNM N/A
  • MBIN $7.36
  • Revenue Growth
  • IMNM N/A
  • MBIN N/A
  • 52 Week Low
  • IMNM $5.15
  • MBIN $27.25
  • 52 Week High
  • IMNM $18.79
  • MBIN $43.82
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 64.32
  • MBIN 41.51
  • Support Level
  • IMNM $16.11
  • MBIN $31.03
  • Resistance Level
  • IMNM $17.94
  • MBIN $32.87
  • Average True Range (ATR)
  • IMNM 1.26
  • MBIN 0.84
  • MACD
  • IMNM 0.02
  • MBIN -0.02
  • Stochastic Oscillator
  • IMNM 86.56
  • MBIN 7.86

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

Share on Social Networks: